- Home
- TTWO vs ARGX Comparison
TTWO vs ARGX Comparison
Compare TTWO & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTWO
- ARGX
- Stock Information
- Founded
- TTWO 1993
- ARGX 2008
- Country
- TTWO United States
- ARGX Netherlands
- Employees
- TTWO N/A
- ARGX N/A
- Industry
- TTWO Computer Software: Prepackaged Software
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTWO Technology
- ARGX Health Care
- Exchange
- TTWO Nasdaq
- ARGX Nasdaq
- Market Cap
- TTWO 32.6B
- ARGX 37.3B
- IPO Year
- TTWO 1997
- ARGX 2017
- Fundamental
- Price
- TTWO $185.14
- ARGX $647.39
- Analyst Decision
- TTWO Strong Buy
- ARGX Strong Buy
- Analyst Count
- TTWO 20
- ARGX 20
- Target Price
- TTWO $203.11
- ARGX $653.11
- AVG Volume (30 Days)
- TTWO 1.3M
- ARGX 250.8K
- Earning Date
- TTWO 02-06-2025
- ARGX 02-27-2025
- Dividend Yield
- TTWO N/A
- ARGX N/A
- EPS Growth
- TTWO N/A
- ARGX N/A
- EPS
- TTWO N/A
- ARGX N/A
- Revenue
- TTWO $5,457,000,000.00
- ARGX $1,908,659,000.00
- Revenue This Year
- TTWO $7.22
- ARGX $70.98
- Revenue Next Year
- TTWO $45.83
- ARGX $51.22
- P/E Ratio
- TTWO N/A
- ARGX N/A
- Revenue Growth
- TTWO 0.35
- ARGX 85.56
- 52 Week Low
- TTWO $135.24
- ARGX $349.86
- 52 Week High
- TTWO $192.14
- ARGX $678.21
- Technical
- Relative Strength Index (RSI)
- TTWO 53.12
- ARGX 56.11
- Support Level
- TTWO $177.35
- ARGX $639.78
- Resistance Level
- TTWO $192.14
- ARGX $678.21
- Average True Range (ATR)
- TTWO 3.95
- ARGX 15.44
- MACD
- TTWO -0.06
- ARGX -0.45
- Stochastic Oscillator
- TTWO 52.67
- ARGX 52.74
About TTWO Take-Two Interactive Software Inc.
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.